Abstract
Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure. Despite improving survival in recent years, patient morbidity and mortality remain high, and there are few evidence-based therapeutic interventions known to clearly improve patient outcomes. This scientific statement on cardiogenic shock summarizes the epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock; reviews contemporary best medical, surgical, mechanical circulatory support, and palliative care practices; advocates for the development of regionalized systems of care; and outlines future research priorities.
Original language | English (US) |
---|---|
Pages (from-to) | e232-e268 |
Journal | Circulation |
Volume | 136 |
Issue number | 16 |
DOIs | |
State | Published - Oct 17 2017 |
Keywords
- AHA Scientific Statements
- delivery of health care
- disease management
- shock, cardiogenic
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)